FY2026 Earnings Forecast for Savaria Issued By Scotiabank

Key Points

• Scotiabank projects Savaria EPS of C$1.38 for FY2026, above the current consensus estimate of C$1.20, and forecasts C$1.51 EPS for FY2027.
• Analyst sentiment remains positive: Savaria has an average “Buy” rating and an average price target of C$34.35, with several firms recently raising targets or upgrading the stock.
• Savaria shares opened at C$29.60, near their 52-week high of C$31.95; insiders sold 74,511 shares worth approximately C$2.24 million during the last quarter.

Savaria Co. (TSE:SIS - Free Report) - Investment analysts at Scotiabank issued their FY2026 earnings estimates for Savaria in a report released on Tuesday, October 13th. Scotiabank analyst J. Goldman expects that the company will post earnings per share of $1.38 for the year. The consensus estimate for Savaria's current full-year earnings is $1.20 per share. Scotiabank also issued estimates for Savaria's FY2027 earnings at $1.51 EPS.

SIS has been the subject of a number of other reports. ATB Cormark Capital Markets raised their price objective on Savaria from C$35.00 to C$38.00 and gave the stock an "outperform" rating in a research report on Friday, August 7th. Ventum Financial set a C$34.50 target price on Savaria and gave the company a "buy" rating in a report on Thursday, September 10th. TD Securities upgraded Savaria to a "strong-buy" rating in a report on Friday, July 24th. Desjardins increased their price target on shares of Savaria from C$36.00 to C$39.00 and gave the stock a "buy" rating in a research report on Friday, August 7th. Finally, TD raised their price target on shares of Savaria from C$35.00 to C$37.00 and gave the stock a "buy" rating in a report on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating and nine have assigned a Buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Buy" and an average target price of C$34.35.

Savaria Stock Performance

Shares of SIS stock opened at C$29.60 on Friday. The company has a market capitalization of C$2.13 billion, a price-to-earnings ratio of 24.46, a P/E/G ratio of 42.72 and a beta of 0.80. Savaria has a 1-year low of C$20.72 and a 1-year high of C$31.95. The company has a current ratio of 1.72, a quick ratio of 0.91 and a debt-to-equity ratio of 29.43. The stock's fifty day simple moving average is C$28.89 and its 200-day simple moving average is C$29.11.

Savaria (TSE:SIS - Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported C$0.35 earnings per share for the quarter. Savaria had a net margin of 9.27% and a return on equity of 13.41%. The business had revenue of C$245.78 million for the quarter.

Insider Activity

In related news, Director Les Teague sold 5,000 shares of the business's stock in a transaction that occurred on Tuesday, September 22nd. The stock was sold at an average price of C$29.52, for a total value of C$147,600.00. Also, insider Jean-Philippe De Montigny sold 10,000 shares of the business's stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of C$29.21, for a total value of C$292,100.00. Following the completion of the sale, the insider owned 82,560 shares of the company's stock, valued at approximately C$2,411,577.60. This trade represents a 10.80% decrease in their ownership of the stock. In the last quarter, insiders have sold 74,511 shares of company stock valued at $2,239,313. Insiders own 17.45% of the company's stock.

Savaria Company Profile

Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.